Baxter International Inc. Share Price Berne S.E.
Equities
BAX
US0718131099
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
38.11 CHF | +3.50% |
|
-.--% | -.--% |
Sales 2024 * | 15.11B 13.47B 1,194B | Sales 2025 * | 15.66B 13.96B 1,237B | Capitalization | 17.19B 15.32B 1,357B |
---|---|---|---|---|---|
Net income 2024 * | 703M 626M 55.52B | Net income 2025 * | 950M 846M 75.02B | EV / Sales 2024 * | 1.79 x |
Net Debt 2024 * | 9.85B 8.77B 778B | Net Debt 2025 * | 9.06B 8.07B 715B | EV / Sales 2025 * | 1.68 x |
P/E ratio 2024 * |
18.4
x | P/E ratio 2025 * |
15.1
x | Employees | - |
Yield 2024 * |
3.54% | Yield 2025 * |
3.68% | Free-Float | 74.27% |
Latest transcript on Baxter International Inc.
1 day | +3.50% |
Managers | Title | Age | Since |
---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 61 | 30/09/15 |
Joel Grade
DFI | Director of Finance/CFO | 54 | 17/10/23 |
Reaz Rasul
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Oesterle
BRD | Director/Board Member | 73 | 05/02/17 |
Peter Wilver
BRD | Director/Board Member | 64 | 09/05/22 |
Director/Board Member | 64 | 17/02/19 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.82% | 181B | |
-3.05% | 105B | |
-2.68% | 67.55B | |
-6.41% | 46.39B | |
+4.82% | 40.93B | |
+20.35% | 31.63B | |
+12.18% | 24.28B | |
-6.85% | 23.46B | |
-12.93% | 21.95B |
- Stock Market
- Equities
- BAX Stock
- BAX Stock